Navigation Links
Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
Date:10/24/2013

gents or other PD-1 inhibitors.  Beyond this challenge, the cost of combining such therapies could prove to be prohibitive considering that Yervoy alone costs $120,000 for four doses administered over 12 weeks.

From an Aethlon Medical perspective, the Wall Street Journal article serves to reinforce our vision that a medical device can deliver immunotherapeutic benefit to both established and candidate cancer therapies, and do so economically and without added drug toxicity.

Our device strategy targets a survival mechanism deployed by tumors to evade and defeat the immune system of cancer patients.  This mechanism, which is not addressed by drug therapies, is the seretion of exosomes by cancerous tumors.  Researchers have discovered that tumors release these particles to trigger the death of cancer fighting immune cells and facilitate the spread of metastasis.  Additionally, the systemic elimination of exosomes may represent a novel strategy to inhibit the PD-1 molecular pathway.  To date, researchers have demonstrated that the Aethlon Hemopurifier® can capture exosomes underlying lymphoma, melanoma, ovarian, and breast cancer. If you are not familiar with the Hemopurifier®, it is a first-in-class medical device that targets the rapid elimination of life-threatening infectious viruses and tumor-secreted exosomes from circulation.  

Based on the recent approval (after 5+ years of effort) of an investigational device exemption (IDE) by FDA, we are preparing to initiate the first U.S. studies of Hemopurifier® therapy in Hepatitis-C (HCV) infected individuals.  In studies previously conducted overseas, Hemopurifier® therapy was demonstrated to accelerate viral load depletion in hardest-to-treat HCV patients receiving standard-of-care drug therapy.

As a result of crossing the IDE approval threshold, we opened the d
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
2. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
3. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
4. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
5. Aethlon Medical Announces the Appointment of Chetan S. Shah, M.D. to its Board of Directors
6. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
7. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
8. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
9. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
11. Aethlon Medical Discloses CEO Interview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... N.H. , March 2, 2015 /PRNewswire/ ... provider of professional-grade vitamins, supplements, prescription products ... announced a strategic partnership with Anabolic Laboratories, ... for healthcare professionals. This new partnership will ... into new licensed healthcare practitioner segments and ...
(Date:3/2/2015)... March 2, 2015  BC Technical, the nation,s ... acquired Eclipse Systems, a Nuclear Imaging service company ... part of their ongoing vision to provide the ... rate, BC Technical continues to expand their reach ... to add valuable resources and knowledge in addition ...
(Date:3/2/2015)... Corporation (NYSE: XON ), a leader ... and full year results for 2014.  ... Acquired ActoGeniX, a European clinical stage biopharmaceutical company ... other innovative products.  Its proprietary TopAct™ platform enables ... lactis ) to generate biologically-contained ActoBiotics™ for in ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3BC Technical Acquires Eclipse Systems 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24
... Calif., Nov. 19 WaferGen Biosystems, Inc. (OTC ... genetic analysis systems, today announced a new, innovative ... using the SmartChip(TM) Real-Time PCR System. By ... WaferGen will offer universities, pharmaceutical and diagnostic companies ...
... , SAN DIEGO, Nov. 19 ... first point-of-care method for measuring platelet reactivity, announces that ... methods evaluated in the POPular study, which was presented ... American Heart Association,s annual Scientific Sessions. The VerifyNow P2Y12 ...
Cached Medicine Technology:WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 4VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests 2
(Date:3/3/2015)... 2015 HealthCarePoint (HCP) , ... announced today that it has completed development of ... Interchange Standards Consortium (CDISC). HCP will continue to ... knowledge-based training and certifications globally. HCP’s in-kind services ... support as well as development of dynamic identification ...
(Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
(Date:3/3/2015)... Join colleagues from across the continent at ... The Learning Summit is a working retreat for community ... explore strategies for focusing entire colleges on improving and ... at the Community College Research Center, Teachers College, Columbia ... Monday through Wednesday, the program will devote a half-day ...
(Date:3/2/2015)... Getting customers to discover a whole new world in ... the 31st annual Frozen Food Month kicks off. The ... Foods Association (NFRA) to stimulate the awareness and options ... frozen selections and is thrilled to be part of ... crafted with simple ingredients, no preservatives or artificial ingredients. ...
(Date:3/2/2015)... Dr. David Knepp, a leading chiropractor ... Doctors on Liens to bring his medical ... for personal injury victims to have access to multiple ... lien basis. However, San Diego Chiropractic Group ... M.D., pain management physician, massage, and acupuncture to help ...
Breaking Medicine News(10 mins):Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3Health News:Register Today for the League for Innovation in the Community College’s Learning Summit 2015 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2
... the University of Pennsylvania School of Medicine in,Philadelphia, USA, has ... day have,impaired mental ability much similar to those who go ... was published in the March issue of the,journal Sleep involved ... hours a night for two weeks, the second group slept ...
... of Neurology, London has shown that,there are several preliminaries ... with migraine attacks that identification of these symptoms,would give ... it better.// ,The group of 97 participants were ... attack on a daily basis for three months. The ...
... rules that would help improve patient safety by reducing medication ... as many as 7,000 deaths. These errors have been attributed ... doctors on prescriptions, or too many new drugs for doctors ... 1999 study reported// between 45,000 and 98,000 death due to ...
... Stargardt's macular degeneration, also called juvenile macular degeneration, is ... people. This condition results from a defect in the ... protein that removes all-trans-retinaldehyde, a vision byproduct, from retinal ... retinal-pigmented epithelium (RPE), a layer of cells near the ...
... Health and Nutrition Examination Survey has now uncovered a ... is a form of gum disease that causes infection ... teeth. The participants of the study where divided into ... from the teeth, an indicator of the presence of ...
... heart beat, during recovery after exercise has been found ... increased risk of death and one that occurs during ... with no history of heart failure, valve disease or ... see if frequent ventricular ectopy occurred and when it ...
Cached Medicine News:
CTAD tubes contain theophylline, adenosine and dipyridamol. Coagulation and DTAD tubes are for examination of coagulation parameters....
... Coagulation tubes contain a ... is available with a citrate ... or 0.129 mol/l (3.8%). The ... citrate solution to 9 parts ...
Inquire...
Inquire...
Medicine Products: